Drug Delivery Spin-Off Adds OTC
This article was originally published in Start Up
Executive Summary
Vectura, focused on pulmonary drug delivery, has created a spin off which assembles the oral and dermal technologies it had already de-prioritized, with two enabling technologies from Unilever. PharmaKodex Ltd. will develop OTC drugs as a fast route to market, followed by Rx products using the same technologies.